BioSpace News Archive

Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors

Data from Phase 1 Study Supports Ongoing INTRIGUE Phase 3 Clinical Study in Patients with Second-line GIST

August 13, 2019

·

11 min read

Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

Deciphera Pharmaceuticals, Inc. announced positive top-line data from the INVICTUS pivotal Phase 3 clinical study of ripretinib, a broad-spectrum KIT and PDGFRα inhibitor, in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors.

August 13, 2019

·

12 min read

Drug Development

CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study

CStone Pharmaceuticals announces the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company’s partner Blueprint Medicines.

August 13, 2019

·

6 min read

BioCapital

New Research Identifies How Microbiome Can Increase Risk or Protection Against Sexually Transmitted Infections (STIs)

New research, published today in the flagship journal of the American Society for Microbiology, is the first to identify a specific mechanism by which keystone species of bacteria in the vaginal microbiome affect a woman’s susceptibility to sexually transmitted infections.

August 13, 2019

·

4 min read

Drug Development

Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc. announced the interim results of an ongoing Phase 1 clinical trial of TERN-201, a semicarbazide-sensitive amine oxidase inhibitor, being developed for the treatment of NASH.

August 13, 2019

·

4 min read

Business

Seven Bridges Expands Operations in Serbia to Facilitate Rapid Growth

Seven Bridges, the industry-leading bioinformatics solution provider, announced plans to expand operations into Novi Sad, Serbia in support of their growing customer base and to expedite product innovation.

August 13, 2019

·

2 min read

Business

DarioHealth Reports Results For Second Quarter 2019

Global digital therapeutics innovator DarioHealth Corp., reported financial and operational results for the second quarter ended June 30, 2019.

August 13, 2019

·

11 min read

Pharm Country

Recovery Centers of America Opens Second Medication Assisted Treatment (“MAT”) Center in South Jersey to Meet Increased Treatment Need for Opioid Addicted Patients

The aftermath of the deluge of prescription pain pills that flooded New Jersey and other states in the last decade continues to cause an increased need for addiction treatment services for opioid dependency.

August 13, 2019

·

3 min read

BioMidwest

Pursuit Vascular’s ClearGuard HD Caps Recommended for Preventing Bloodstream Infection

The July edition highlights the significant reduction in central-line associated bloodstream infection rates using ClearGuard HD caps vs. other commonly used caps.

August 13, 2019

·

2 min read

Drug Development

Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results

FDA agrees to allow initiation of NODE-303 open-label safety study without test dose and in population consistent with ongoing studies

August 13, 2019

·

12 min read